{"entity":{"type":"insider","cik":"0001477123","url":"/insider/0001477123","json_url":"/insider/0001477123.json","name":"Segal Lloyd Mitchell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":15,"first":"2012-11-08","last":"2025-03-14","span_basis":"filed_date"},"name_variants":[{"name":"Segal Lloyd Mitchell","source":"filing","n_filings":15,"first_seen":"2012-11-08","last_seen":"2025-03-14"}],"transactions":[{"id":4500658,"accession":"0001415889-25-008105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008105","line_url":"/filing/0001415889-25-008105#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21179.0,"shares_display":"21,179","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":24144.06,"total_display":"24,144.06","total_whole":"24,144","shares_owned_after":124394.0,"shares_owned_after_display":"124,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":2369452,"accession":"0001415889-24-009629","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009629","line_url":"/filing/0001415889-24-009629#line-2","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2491.0,"shares_display":"2,491","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":11533.33,"total_display":"11,533.33","total_whole":"11,533","shares_owned_after":107558.0,"shares_owned_after_display":"107,558","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-01","scope":"insider"},{"id":2369449,"accession":"0001415889-24-009629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009629","line_url":"/filing/0001415889-24-009629#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":4.62,"price_display":"4.62","price_state":"stated","total_value":12243.0,"total_display":"12,243.00","total_whole":"12,243","shares_owned_after":110049.0,"shares_owned_after_display":"110,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":2999387,"accession":"0001415889-24-009249","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-009249","line_url":"/filing/0001415889-24-009249#line-3","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":12269.5,"total_display":"12,269.50","total_whole":"12,270","shares_owned_after":83866.0,"shares_owned_after_display":"83,866","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-27","scope":"insider"},{"id":2999383,"accession":"0001415889-24-009249","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009249","line_url":"/filing/0001415889-24-009249#line-2","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":4.64,"price_display":"4.64","price_state":"stated","total_value":12296.0,"total_display":"12,296.00","total_whole":"12,296","shares_owned_after":86516.0,"shares_owned_after_display":"86,516","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-26","filed_date":"2024-03-27","scope":"insider"},{"id":2999379,"accession":"0001415889-24-009249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009249","line_url":"/filing/0001415889-24-009249#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":4.79,"price_display":"4.79","price_state":"stated","total_value":12693.5,"total_display":"12,693.50","total_whole":"12,694","shares_owned_after":89166.0,"shares_owned_after_display":"89,166","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-27","scope":"insider"},{"id":4181580,"accession":"0001209191-21-044032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-044032","line_url":"/filing/0001209191-21-044032#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1542.0,"shares_display":"1,542","price_per_share":35.61,"price_display":"35.61","price_state":"stated","total_value":54910.62,"total_display":"54,910.62","total_whole":"54,911","shares_owned_after":94466.0,"shares_owned_after_display":"94,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider"},{"id":5251094,"accession":"0001209191-21-039621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-039621","line_url":"/filing/0001209191-21-039621#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1576.0,"shares_display":"1,576","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":55160.0,"total_display":"55,160.00","total_whole":"55,160","shares_owned_after":96008.0,"shares_owned_after_display":"96,008","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-10","scope":"insider"},{"id":4274260,"accession":"0001209191-21-038747","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-038747","line_url":"/filing/0001209191-21-038747","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34352.0,"shares_display":"34,352","price_per_share":30.98390544946437,"price_display":"30.98","price_state":"stated","total_value":1064359.12,"total_display":"1,064,359.12","total_whole":"1,064,359","shares_owned_after":109756.0,"shares_owned_after_display":"109,756","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-07","scope":"insider","n_lines":3},{"id":4274245,"accession":"0001209191-21-038747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038747","line_url":"/filing/0001209191-21-038747#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6648.0,"shares_display":"6,648","price_per_share":31.74,"price_display":"31.74","price_state":"stated","total_value":211007.52,"total_display":"211,007.52","total_whole":"211,008","shares_owned_after":126936.0,"shares_owned_after_display":"126,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-07","scope":"insider"},{"id":5398610,"accession":"0001209191-21-034874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034874","line_url":"/filing/0001209191-21-034874#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3770.0,"shares_display":"3,770","price_per_share":35.0306,"price_display":"35.03","price_state":"stated","total_value":132065.362,"total_display":"132,065.36","total_whole":"132,065","shares_owned_after":133584.0,"shares_owned_after_display":"133,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-21","scope":"insider"},{"id":5100486,"accession":"0001209191-21-034571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-034571","line_url":"/filing/0001209191-21-034571#line-2","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":35.06,"price_display":"35.06","price_state":"stated","total_value":133228.0,"total_display":"133,228.00","total_whole":"133,228","shares_owned_after":137354.0,"shares_owned_after_display":"137,354","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-20","scope":"insider"},{"id":5100482,"accession":"0001209191-21-034571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034571","line_url":"/filing/0001209191-21-034571#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":63000.0,"total_display":"63,000.00","total_whole":"63,000","shares_owned_after":141154.0,"shares_owned_after_display":"141,154","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"},{"id":4728020,"accession":"0001209191-21-027344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-027344","line_url":"/filing/0001209191-21-027344#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5512.0,"shares_display":"5,512","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":192975.12,"total_display":"192,975.12","total_whole":"192,975","shares_owned_after":142954.0,"shares_owned_after_display":"142,954","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-19","scope":"insider"},{"id":2219804,"accession":"0001209191-20-038975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038975","line_url":"/filing/0001209191-20-038975#line-1","is_derivative":false,"issuer_cik":"0001477123","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001477123","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider"},{"id":5434632,"accession":"0000885590-13-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000052","line_url":"/filing/0000885590-13-000052#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":140.0,"shares_display":"140","price_per_share":85.45,"price_display":"85.45","price_state":"stated","total_value":11963.0,"total_display":"11,963.00","total_whole":"11,963","shares_owned_after":21174.0,"shares_owned_after_display":"21,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-18","scope":"insider"},{"id":4572383,"accession":"0000885590-13-000051","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000885590-13-000051","line_url":"/filing/0000885590-13-000051#line-5","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":83.5,"price_display":"83.50","price_state":"stated","total_value":208750.0,"total_display":"208,750.00","total_whole":"208,750","shares_owned_after":21034.0,"shares_owned_after_display":"21,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-12","filed_date":"2013-06-13","scope":"insider"},{"id":4572378,"accession":"0000885590-13-000051","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000885590-13-000051","line_url":"/filing/0000885590-13-000051","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":690.0,"shares_display":"690","price_per_share":86.57420289855072,"price_display":"86.57","price_state":"stated","total_value":59736.2,"total_display":"59,736.20","total_whole":"59,736","shares_owned_after":18534.0,"shares_owned_after_display":"18,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-11","filed_date":"2013-06-13","scope":"insider","n_lines":4},{"id":2825684,"accession":"0000885590-12-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-12-000077","line_url":"/filing/0000885590-12-000077#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":240.0,"shares_display":"240","price_per_share":54.28,"price_display":"54.28","price_state":"stated","total_value":13027.2,"total_display":"13,027.20","total_whole":"13,027","shares_owned_after":17849.0,"shares_owned_after_display":"17,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-11-09","filed_date":"2012-11-14","scope":"insider"},{"id":2713555,"accession":"0000885590-12-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-12-000076","line_url":"/filing/0000885590-12-000076#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":240.0,"shares_display":"240","price_per_share":54.28,"price_display":"54.28","price_state":"stated","total_value":13027.2,"total_display":"13,027.20","total_whole":"13,027","shares_owned_after":17849.0,"shares_owned_after_display":"17,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-11-09","filed_date":"2012-11-14","scope":"insider"},{"id":2330266,"accession":"0000885590-12-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-12-000071","line_url":"/filing/0000885590-12-000071#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001477123","owner_name":"Segal Lloyd Mitchell","owner_display_name":"Segal Lloyd Mitchell","owner_url":"/insider/0001477123","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":745.0,"shares_display":"745","price_per_share":54.437,"price_display":"54.44","price_state":"stated","total_value":40555.565,"total_display":"40,555.56","total_whole":"40,556","shares_owned_after":17609.0,"shares_owned_after_display":"17,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-06","filed_date":"2012-11-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001808158","name":"Repare Therapeutics Inc.","url":"/issuer/0001808158","role":"Director, Officer (PRESIDENT AND CEO)","n_filings":10,"first_seen":"2020-06-25","last_seen":"2025-03-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000885590","name":"Valeant Pharmaceuticals International, Inc.","url":"/issuer/0000885590","role":"Director","n_filings":5,"first_seen":"2012-11-08","last_seen":"2013-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001477123","retrieved_at":"2026-08-23T13:47:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}